Edesa Biotech, Inc. (EDSA)
NASDAQ: EDSA · Real-Time Price · USD
7.14
+0.62 (9.51%)
At close: Mar 9, 2026, 4:00 PM EDT
7.27
+0.13 (1.82%)
After-hours: Mar 9, 2026, 7:59 PM EDT
Edesa Biotech Ratios and Metrics
Market cap in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Mar '26 Mar 9, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
| Market Capitalization | 60 | 17 | 14 | 13 | 14 | 98 | |
| Market Cap Growth | 243.73% | 20.29% | 8.40% | -6.42% | -85.44% | 26.16% | |
| Enterprise Value | 48 | 14 | 12 | 7 | 1 | 90 | |
| Last Close Price | 7.14 | 2.47 | 4.45 | 4.42 | 6.45 | 51.66 | |
| Forward PE | - | - | - | - | 56.67 | - | |
| PB Ratio | 12.78 | 1.40 | 7.29 | 1.89 | 1.52 | 7.49 | |
| P/TBV Ratio | 22.04 | 14.32 | - | 2.74 | 2.00 | 9.16 | |
| Debt / Equity Ratio | - | - | 0.01 | 0.01 | 0.00 | 0.01 | |
| Net Debt / Equity Ratio | -0.86 | -0.87 | -0.51 | -0.75 | -0.75 | -0.59 | |
| Net Debt / EBITDA Ratio | 1.46 | 1.39 | 0.15 | 0.58 | 0.39 | 0.33 | |
| Net Debt / FCF Ratio | 1.53 | 1.47 | 0.21 | 0.79 | 0.58 | 0.57 | |
| Quick Ratio | 16.51 | 10.60 | 0.71 | 3.29 | 3.90 | 7.64 | |
| Current Ratio | 16.82 | 10.68 | 0.91 | 3.53 | 4.25 | 8.29 | |
| Return on Equity (ROE) | -96.38% | -99.57% | -136.66% | -101.88% | -156.34% | -120.39% | |
| Return on Assets (ROA) | -55.33% | -57.02% | -69.02% | -56.33% | -87.78% | -116.79% | |
| Return on Capital Employed (ROCE) | -59.90% | -63.50% | -354.10% | -130.50% | -194.70% | -180.40% | |
| Earnings Yield | -13.11% | -41.34% | -42.70% | -62.82% | -123.19% | -13.64% | |
| FCF Yield | -13.24% | -42.12% | -33.84% | -49.78% | -86.24% | -13.98% | |
| Buyback Yield / Dilution | -110.15% | -77.54% | -11.84% | -36.37% | -21.50% | -40.32% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.